Publications by authors named "Pierre-Alain Vitte"

Claim this Profile
A
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.
Claudia Volpi, Giada Mondanelli, Maria T Pallotta, Carmine Vacca, Alberta Iacono, Pierre-Alain Vitte

Neuropharmacology· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy.
Anna Quattropani, Wolfgang H B Sauer, Stefano Crosignani, Jerome Dorbais, Patrick Gerber, Pierre-Alain Vitte

ChemMedChem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway.
Xiaoli Guo, Chikako Harada, Kazuhiko Namekata, Atsushi Matsuzawa, Monsterrat Camps, Pierre-Alain Vitte

EMBO Mol Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of potent S1P1 agonists.
Stefano Crosignani, Agnes Bombrun, David Covini, Maurizio Maio, Delphine Marin, Pierre-Alain Vitte

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An adiponectin-like molecule with antidiabetic properties.
Thierry Sulpice, Bénédicte Prunet-Marcassus, Cécile Molveaux, Patrice D Cani, Pierre-Alain Vitte

Endocrinology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis.
Rosanna Pescini Gobert, Monique van den Eijnden, Cedric Szyndralewiez, Catherine Jorand-Lebrun, Dominique Swinnen, Pierre-Alain Vitte

J Biol Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
Noelle Callizot, Emile Andriambeloson, Jonathan Glass, Michel Revel, Pamela Ferro, Pierre-Alain Vitte

Cancer Chemother Pharmacol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo.
Tracy M Handel, Zoë Johnson, David H Rodrigues, Adriana C Dos Santos, Rocco Cirillo, Pierre-Alain Vitte

J Leukoc Biol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist.
Sean D McKenna, Georg Feger, Christie Kelton, Meijia Yang, Vittoria Ardissone, Pierre-Alain Vitte

J Pharmacol Exp Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
Vincent Pomel, Jasna Klicic, David Covini, Dennis D Church, Jeffrey P Shaw, Pierre Alain Vitte

J Med Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 attenuates the development of experimental diabetes-related neuropathy.
Emile Andriambeloson, Caroline Baillet, Pierre-Alain Vitte, Gianni Garotta, Michel Dreano

Neuropathology· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia.
Claudio Hetz, Pierre-Alain Vitte, Agnes Bombrun, Tatiana K Rostovtseva, Sylvie Montessuit

J Biol Chem· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.
Montserrat Camps, Thomas Rückle, Hong Ji, Vittoria Ardissone, Felix Rintelen, Pierre-Alain Vitte

Nat Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.
Pascale Gaillard, Isabelle Jeanclaude-Etter, Vittoria Ardissone, Steve Arkinstall, Yves Cambet, Pierre-Alain Vitte

J Med Chem· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient ischaemia.
Sonia Carboni, Bruno Antonsson, Pascale Gaillard, Jean-Pierre Gotteland, Jean-Yves Gillon, Pierre-Alain Vitte

J Neurochem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties.
Sonia Carboni, Agnes Hiver, Cedric Szyndralewiez, Pascale Gaillard, Jean-Pierre Gotteland, Pierre-Alain Vitte

J Pharmacol Exp Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.
Chiara Ferrandi, Rossana Ballerio, Pascale Gaillard, Claudio Giachetti, Sonia Carboni, Pierre-Alain Vitte

Br J Pharmacol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis